Seeking Alpha

Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities

SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced its support for a recent guideline update ...
Forbes

Healing Before Birth: How Genetic Screening Is Changing Lives

Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or inherited diseases. Advances in modern medicine allow us to treat fetuses and newborn babies for genetic or ...
ascopubs.org

Evaluating the cost-effectiveness of genetic testing in high-risk families with confirmed ...

The cost of convenience: Evaluating economic differences in SQ and IV biotherapeutic formulations. Overall – Total Cost per FDR ($1,000s USD) Tested – Total Cost per FDR ($1,000s USD) Untested – Total ...
Nasdaq

Myriad Genetics Study Shows Increased Completion Rates for Hereditary Cancer Testing ...

Myriad Genetics, Inc. announced a study indicating that the use of its online screening tool, MyGeneHistory®, alongside a virtual education program, significantly increased the completion rates for ...